Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 59 entries
Sorted by: Best Match Show Resources per page
Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms.

Oncotarget

Montalban-Bravo G, Takahashi K, Patel K, Wang F, Xingzhi S, Nogueras GM, Huang X, Pierola AA, Jabbour E, Colla S, Gañan-Gomez I, Borthakur G, Daver N, Estrov Z, Kadia T, Pemmaraju N, Ravandi F, Bueso-Ramos C, Chamseddine A, Konopleva M, Zhang J, Kantarjian H, Futreal A, Garcia-Manero G.
PMID: 29515765
Oncotarget. 2018 Jan 03;9(11):9714-9727. doi: 10.18632/oncotarget.23882. eCollection 2018 Feb 09.

The prognostic and predictive value of sequencing analysis in myelodysplastic syndromes (MDS) has not been fully integrated into clinical practice. We performed whole exome sequencing (WES) of bone marrow samples from 83 patients with MDS and 31 with MDS/MPN...

Cite
Montalban-Bravo G, Takahashi K, Patel K, et al. Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms. Oncotarget. 2018;9(11):9714-9727doi: 10.18632/oncotarget.23882.
Montalban-Bravo, G., Takahashi, K., Patel, K., Wang, F., Xingzhi, S., Nogueras, G. M., Huang, X., Pierola, A. A., Jabbour, E., Colla, S., Gañan-Gomez, I., Borthakur, G., Daver, N., Estrov, Z., Kadia, T., Pemmaraju, N., Ravandi, F., Bueso-Ramos, C., Chamseddine, A., Konopleva, M., Zhang, J., Kantarjian, H., Futreal, A., & Garcia-Manero, G. (2018). Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms. Oncotarget, 9(11), 9714-9727. https://doi.org/10.18632/oncotarget.23882
Montalban-Bravo, Guillermo, et al. "Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms." Oncotarget vol. 9,11 (2018): 9714-9727. doi: https://doi.org/10.18632/oncotarget.23882
Montalban-Bravo G, Takahashi K, Patel K, Wang F, Xingzhi S, Nogueras GM, Huang X, Pierola AA, Jabbour E, Colla S, Gañan-Gomez I, Borthakur G, Daver N, Estrov Z, Kadia T, Pemmaraju N, Ravandi F, Bueso-Ramos C, Chamseddine A, Konopleva M, Zhang J, Kantarjian H, Futreal A, Garcia-Manero G. Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms. Oncotarget. 2018 Jan 03;9(11):9714-9727. doi: 10.18632/oncotarget.23882. eCollection 2018 Feb 09. PMID: 29515765; PMCID: PMC5839396.
Copy Download .nbib Format: NLM
5,5-Dimethyl-3-(5-methyl-1H-pyrazol-3-ylamino)cyclohex-3-en-1-one.

Acta crystallographica. Section C, Crystal structure communications

Quiroga J, Insuasty B, Abonia R, Mejia D, Cobo J, Nogueras M, Sanchez A, Low JN.
PMID: 11118988
Acta Crystallogr C. 2000 Dec;56:1457-9. doi: 10.1107/s0108270100012300.

The molecules of the title compound, C(12)H(17)N(3)O, are linked by two N-H.O hydrogen bonds to form a three-dimensional network. The N. O distances are 2.804 (3) and 2.766 (3) A, both involving a common acceptor O atom.

Cite
Quiroga J, Insuasty B, Abonia R, et al. 5,5-Dimethyl-3-(5-methyl-1H-pyrazol-3-ylamino)cyclohex-3-en-1-one. Acta Crystallogr C. 2000;56:1457-9doi: 10.1107/s0108270100012300.
Quiroga, J., Insuasty, B., Abonia, R., Mejia, D., Cobo, J., Nogueras, M., Sanchez, A., & Low, J. N. (2000). 5,5-Dimethyl-3-(5-methyl-1H-pyrazol-3-ylamino)cyclohex-3-en-1-one. Acta crystallographica. Section C, Crystal structure communications, 561457-9. https://doi.org/10.1107/s0108270100012300
Quiroga, et al. "5,5-Dimethyl-3-(5-methyl-1H-pyrazol-3-ylamino)cyclohex-3-en-1-one." Acta crystallographica. Section C, Crystal structure communications vol. 56 (2000): 1457-9. doi: https://doi.org/10.1107/s0108270100012300
Quiroga J, Insuasty B, Abonia R, Mejia D, Cobo J, Nogueras M, Sanchez A, Low JN. 5,5-Dimethyl-3-(5-methyl-1H-pyrazol-3-ylamino)cyclohex-3-en-1-one. Acta Crystallogr C. 2000 Dec;56:1457-9. doi: 10.1107/s0108270100012300. PMID: 11118988.
Copy Download .nbib Format: NLM
Ethyl N-(2-benzylamino-6-benzyloxy-5-nitrosopyrimidin-4-yl)glycinate: sheets built from a three-centre N[bond]H...(N,O), and two-centre C[bond]H...O and C[bond]H...pi(arene) hydrogen bonds.

Acta crystallographica. Section C, Crystal structure communications

Low JN, Glidewell C, Quesada A, Nogueras M, Sánchez A.
PMID: 12094066
Acta Crystallogr C. 2002 Jul;58:o425-7. doi: 10.1107/s0108270102009575. Epub 2002 Jun 20.

In the title compound, C(22)H(23)N(5)O(4), the molecules are linked into chains by a three-centre N[bond]H...(N,O) hydrogen bond, reinforced by a two-centre C[bond]H...O hydrogen bond, and the chains are further linked into sheets by a combination of C[bond]H...O and C[bond]H...pi(arene)...

Cite
Low JN, Glidewell C, Quesada A, et al. Ethyl N-(2-benzylamino-6-benzyloxy-5-nitrosopyrimidin-4-yl)glycinate: sheets built from a three-centre N[bond]H...(N,O), and two-centre C[bond]H...O and C[bond]H...pi(arene) hydrogen bonds. Acta Crystallogr C. 2002;58:o425-7doi: 10.1107/s0108270102009575.
Low, J. N., Glidewell, C., Quesada, A., Nogueras, M., & Sánchez, A. (2002). Ethyl N-(2-benzylamino-6-benzyloxy-5-nitrosopyrimidin-4-yl)glycinate: sheets built from a three-centre N[bond]H...(N,O), and two-centre C[bond]H...O and C[bond]H...pi(arene) hydrogen bonds. Acta crystallographica. Section C, Crystal structure communications, 58o425-7. https://doi.org/10.1107/s0108270102009575
Low, John N, et al. "Ethyl N-(2-benzylamino-6-benzyloxy-5-nitrosopyrimidin-4-yl)glycinate: sheets built from a three-centre N[bond]H...(N,O), and two-centre C[bond]H...O and C[bond]H...pi(arene) hydrogen bonds." Acta crystallographica. Section C, Crystal structure communications vol. 58 (2002): o425-7. doi: https://doi.org/10.1107/s0108270102009575
Low JN, Glidewell C, Quesada A, Nogueras M, Sánchez A. Ethyl N-(2-benzylamino-6-benzyloxy-5-nitrosopyrimidin-4-yl)glycinate: sheets built from a three-centre N[bond]H...(N,O), and two-centre C[bond]H...O and C[bond]H...pi(arene) hydrogen bonds. Acta Crystallogr C. 2002 Jul;58:o425-7. doi: 10.1107/s0108270102009575. Epub 2002 Jun 20. PMID: 12094066.
Copy Download .nbib Format: NLM
4-(allylamino)-2-amino-6-benzyloxy-5-nitrosopyrimidine from synchrotron data at 150 K: double chains built from N[bond]H...N, N[bond]H...O, N[bond]H...pi(arene) and aromatic pi-pi-stacking interactions.

Acta crystallographica. Section C, Crystal structure communications

MacLean EJ, Low JN, Quesada A, Melguizo M, Nogueras M, Glidewell C.
PMID: 12094072
Acta Crystallogr C. 2002 Jul;58:o442-4. doi: 10.1107/s0108270102010387. Epub 2002 Jun 29.

In the title compound, C(14)H(15)N(5)O(2), the intramolecular dimensions are consistent with a highly polarized electronic structure. The molecules are linked into chains by a combination of N[bond]H...N, N[bond]H...O and N[bond]H...pi(arene) hydrogen bonds, and the chains are linked in pairs...

Cite
MacLean EJ, Low JN, Quesada A, et al. 4-(allylamino)-2-amino-6-benzyloxy-5-nitrosopyrimidine from synchrotron data at 150 K: double chains built from N[bond]H...N, N[bond]H...O, N[bond]H...pi(arene) and aromatic pi-pi-stacking interactions. Acta Crystallogr C. 2002;58:o442-4doi: 10.1107/s0108270102010387.
MacLean, E. J., Low, J. N., Quesada, A., Melguizo, M., Nogueras, M., & Glidewell, C. (2002). 4-(allylamino)-2-amino-6-benzyloxy-5-nitrosopyrimidine from synchrotron data at 150 K: double chains built from N[bond]H...N, N[bond]H...O, N[bond]H...pi(arene) and aromatic pi-pi-stacking interactions. Acta crystallographica. Section C, Crystal structure communications, 58o442-4. https://doi.org/10.1107/s0108270102010387
MacLean, Elizabeth J, et al. "4-(allylamino)-2-amino-6-benzyloxy-5-nitrosopyrimidine from synchrotron data at 150 K: double chains built from N[bond]H...N, N[bond]H...O, N[bond]H...pi(arene) and aromatic pi-pi-stacking interactions." Acta crystallographica. Section C, Crystal structure communications vol. 58 (2002): o442-4. doi: https://doi.org/10.1107/s0108270102010387
MacLean EJ, Low JN, Quesada A, Melguizo M, Nogueras M, Glidewell C. 4-(allylamino)-2-amino-6-benzyloxy-5-nitrosopyrimidine from synchrotron data at 150 K: double chains built from N[bond]H...N, N[bond]H...O, N[bond]H...pi(arene) and aromatic pi-pi-stacking interactions. Acta Crystallogr C. 2002 Jul;58:o442-4. doi: 10.1107/s0108270102010387. Epub 2002 Jun 29. PMID: 12094072.
Copy Download .nbib Format: NLM
5-[N-(1H-Benzotriazol-1-ylmethyl)amino]-3-tert-butyl-1-phenylpyrazole: sheets built from N[bond]H...N, C[bond]H...N and C[bond]H...pi(pyrazole) interactions.

Acta crystallographica. Section C, Crystal structure communications

Glidewell C, Low JN, Cobo J, Nogueras M, Sánchez A, Rengifo E, Abonia R.
PMID: 12050426
Acta Crystallogr C. 2002 Jun;58:o314-7. doi: 10.1107/s0108270102006881. Epub 2002 May 11.

In the title compound, C(20)H(22)N(6), the molecules are linked into a chain of rings by N[bond]H...N [H...N 2.16 A, N...N 2.950 (3) A and N[bond]H...N 149 degrees] and C[bond]H...N [H...N 2.55 A, C...N 3.481 (3) A and C[bond]H...N 165...

Cite
Glidewell C, Low JN, Cobo J, et al. 5-[N-(1H-Benzotriazol-1-ylmethyl)amino]-3-tert-butyl-1-phenylpyrazole: sheets built from N[bond]H...N, C[bond]H...N and C[bond]H...pi(pyrazole) interactions. Acta Crystallogr C. 2002;58:o314-7doi: 10.1107/s0108270102006881.
Glidewell, C., Low, J. N., Cobo, J., Nogueras, M., Sánchez, A., Rengifo, E., & Abonia, R. (2002). 5-[N-(1H-Benzotriazol-1-ylmethyl)amino]-3-tert-butyl-1-phenylpyrazole: sheets built from N[bond]H...N, C[bond]H...N and C[bond]H...pi(pyrazole) interactions. Acta crystallographica. Section C, Crystal structure communications, 58o314-7. https://doi.org/10.1107/s0108270102006881
Glidewell, Christopher, et al. "5-[N-(1H-Benzotriazol-1-ylmethyl)amino]-3-tert-butyl-1-phenylpyrazole: sheets built from N[bond]H...N, C[bond]H...N and C[bond]H...pi(pyrazole) interactions." Acta crystallographica. Section C, Crystal structure communications vol. 58 (2002): o314-7. doi: https://doi.org/10.1107/s0108270102006881
Glidewell C, Low JN, Cobo J, Nogueras M, Sánchez A, Rengifo E, Abonia R. 5-[N-(1H-Benzotriazol-1-ylmethyl)amino]-3-tert-butyl-1-phenylpyrazole: sheets built from N[bond]H...N, C[bond]H...N and C[bond]H...pi(pyrazole) interactions. Acta Crystallogr C. 2002 Jun;58:o314-7. doi: 10.1107/s0108270102006881. Epub 2002 May 11. PMID: 12050426.
Copy Download .nbib Format: NLM
Effect of age on the functional outcome of total abdominal colectomy for colonic inertia.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

Pikarsky AJ, Efron J, Hamel CT, Weiss EG, Nogueras JJ, Wexner SD.
PMID: 12790953
Colorectal Dis. 2001 Sep;3(5):318-22. doi: 10.1046/j.1463-1318.2001.00259.x.

OBJECTIVE: Colonic inertia (CI) usually presents in women in the third decade of life; however, elderly patients are at times diagnosed with the disease. Total abdominal colectomy (TAC) is considered the preferred surgical treatment for patients with well established...

Cite
Pikarsky AJ, Efron J, Hamel CT, et al. Effect of age on the functional outcome of total abdominal colectomy for colonic inertia. Colorectal Dis. 2001;3(5):318-22doi: 10.1046/j.1463-1318.2001.00259.x.
Pikarsky, A. J., Efron, J., Hamel, C. T., Weiss, E. G., Nogueras, J. J., & Wexner, S. D. (2001). Effect of age on the functional outcome of total abdominal colectomy for colonic inertia. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 3(5), 318-22. https://doi.org/10.1046/j.1463-1318.2001.00259.x
Pikarsky, A J, et al. "Effect of age on the functional outcome of total abdominal colectomy for colonic inertia." Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland vol. 3,5 (2001): 318-22. doi: https://doi.org/10.1046/j.1463-1318.2001.00259.x
Pikarsky AJ, Efron J, Hamel CT, Weiss EG, Nogueras JJ, Wexner SD. Effect of age on the functional outcome of total abdominal colectomy for colonic inertia. Colorectal Dis. 2001 Sep;3(5):318-22. doi: 10.1046/j.1463-1318.2001.00259.x. PMID: 12790953.
Copy Download .nbib Format: NLM
Layer-by-layer deposited chitosan/silk fibroin thin films with anisotropic nanofiber alignment.

Langmuir : the ACS journal of surfaces and colloids

Nogueira GM, Swiston AJ, Beppu MM, Rubner MF.
PMID: 20158176
Langmuir. 2010 Jun 01;26(11):8953-8. doi: 10.1021/la904741h.

Chitosan/silk fibroin multilayer thin films were assembled using layer-by-layer deposition. The resultant multilayer films contained nanofibers aligned parallel to the dipping direction. Fiber deposition and orientation was enabled uniquely by a judicious choice of solvent and drying conditions and...

Cite
Nogueira GM, Swiston AJ, Beppu MM, et al. Layer-by-layer deposited chitosan/silk fibroin thin films with anisotropic nanofiber alignment. Langmuir. 2010;26(11):8953-8doi: 10.1021/la904741h.
Nogueira, G. M., Swiston, A. J., Beppu, M. M., & Rubner, M. F. (2010). Layer-by-layer deposited chitosan/silk fibroin thin films with anisotropic nanofiber alignment. Langmuir : the ACS journal of surfaces and colloids, 26(11), 8953-8. https://doi.org/10.1021/la904741h
Nogueira, Grinia M, et al. "Layer-by-layer deposited chitosan/silk fibroin thin films with anisotropic nanofiber alignment." Langmuir : the ACS journal of surfaces and colloids vol. 26,11 (2010): 8953-8. doi: https://doi.org/10.1021/la904741h
Nogueira GM, Swiston AJ, Beppu MM, Rubner MF. Layer-by-layer deposited chitosan/silk fibroin thin films with anisotropic nanofiber alignment. Langmuir. 2010 Jun 01;26(11):8953-8. doi: 10.1021/la904741h. PMID: 20158176.
Copy Download .nbib Format: NLM
Slow transit constipation: a review of a colonic functional disorder.

Clinics in colon and rectal surgery

Frattini JC, Nogueras JJ.
PMID: 20011411
Clin Colon Rectal Surg. 2008 May;21(2):146-52. doi: 10.1055/s-2008-1075864.

Constipation is a common gastrointestinal complaint that can cause significant physical and psychosocial problems. It has been categorized as slow transit constipation, normal transit constipation, and obstructed defecation. Both the definition and pathophysiology of constipation are unclear, but attempts...

Cite
Frattini JC, Nogueras JJ. Slow transit constipation: a review of a colonic functional disorder. Clin Colon Rectal Surg. 2008;21(2):146-52doi: 10.1055/s-2008-1075864.
Frattini, J. C., & Nogueras, J. J. (2008). Slow transit constipation: a review of a colonic functional disorder. Clinics in colon and rectal surgery, 21(2), 146-52. https://doi.org/10.1055/s-2008-1075864
Frattini, Jared C, and Nogueras, Juan J. "Slow transit constipation: a review of a colonic functional disorder." Clinics in colon and rectal surgery vol. 21,2 (2008): 146-52. doi: https://doi.org/10.1055/s-2008-1075864
Frattini JC, Nogueras JJ. Slow transit constipation: a review of a colonic functional disorder. Clin Colon Rectal Surg. 2008 May;21(2):146-52. doi: 10.1055/s-2008-1075864. PMID: 20011411; PMCID: PMC2780201.
Copy Download .nbib Format: NLM
Bats from different foraging guilds prey upon the pine processionary moth.

PeerJ

Garin I, Aihartza J, Goiti U, Arrizabalaga-Escudero A, Nogueras J, Ibáñez C.
PMID: 31316870
PeerJ. 2019 Jul 05;7:e7169. doi: 10.7717/peerj.7169. eCollection 2019.

Outbreaks of the processionary moth

Cite
Garin I, Aihartza J, Goiti U, et al. Bats from different foraging guilds prey upon the pine processionary moth. PeerJ. 2019;7:e7169doi: 10.7717/peerj.7169.
Garin, I., Aihartza, J., Goiti, U., Arrizabalaga-Escudero, A., Nogueras, J., & Ibáñez, C. (2019). Bats from different foraging guilds prey upon the pine processionary moth. PeerJ, 7e7169. https://doi.org/10.7717/peerj.7169
Garin, Inazio, et al. "Bats from different foraging guilds prey upon the pine processionary moth." PeerJ vol. 7 (2019): e7169. doi: https://doi.org/10.7717/peerj.7169
Garin I, Aihartza J, Goiti U, Arrizabalaga-Escudero A, Nogueras J, Ibáñez C. Bats from different foraging guilds prey upon the pine processionary moth. PeerJ. 2019 Jul 05;7:e7169. doi: 10.7717/peerj.7169. eCollection 2019. PMID: 31316870; PMCID: PMC6613530.
Copy Download .nbib Format: NLM
A PROPRIETARY GMP HUMAN PLATELET LYSATE FOR THE EXPANSION OF DERMAL FIBROBLASTS FOR CLINICAL APPLICATIONS.

Platelets

Fernández Muñoz B, Lopez-Navas L, Gonzalez Bermejo M, Lomas Romero IM, Montiel Aguilera MÁ, Campos Cuerva R, Arribas Arribas B, Nogueras S, Carmona Sánchez G, Santos González M.
PMID: 33393414
Platelets. 2021 Jan 03;1-12. doi: 10.1080/09537104.2020.1856356. Epub 2021 Jan 03.

Recent years have witnessed the introduction of

Cite
Fernández Muñoz B, Lopez-Navas L, Gonzalez Bermejo M, et al. A PROPRIETARY GMP HUMAN PLATELET LYSATE FOR THE EXPANSION OF DERMAL FIBROBLASTS FOR CLINICAL APPLICATIONS. Platelets. 2021;1-12doi: 10.1080/09537104.2020.1856356.
Fernández Muñoz, B., Lopez-Navas, L., Gonzalez Bermejo, M., Lomas Romero, I. M., Montiel Aguilera, M. �. �., Campos Cuerva, R., Arribas Arribas, B., Nogueras, S., Carmona Sánchez, G., & Santos González, M. (2021). A PROPRIETARY GMP HUMAN PLATELET LYSATE FOR THE EXPANSION OF DERMAL FIBROBLASTS FOR CLINICAL APPLICATIONS. Platelets, 1-12. https://doi.org/10.1080/09537104.2020.1856356
Fernández Muñoz, Beatriz, et al. "A PROPRIETARY GMP HUMAN PLATELET LYSATE FOR THE EXPANSION OF DERMAL FIBROBLASTS FOR CLINICAL APPLICATIONS." Platelets vol. (2021): 1-12. doi: https://doi.org/10.1080/09537104.2020.1856356
Fernández Muñoz B, Lopez-Navas L, Gonzalez Bermejo M, Lomas Romero IM, Montiel Aguilera MÁ, Campos Cuerva R, Arribas Arribas B, Nogueras S, Carmona Sánchez G, Santos González M. A PROPRIETARY GMP HUMAN PLATELET LYSATE FOR THE EXPANSION OF DERMAL FIBROBLASTS FOR CLINICAL APPLICATIONS. Platelets. 2021 Jan 03;1-12. doi: 10.1080/09537104.2020.1856356. Epub 2021 Jan 03. PMID: 33393414.
Copy Download .nbib Format: NLM
COVID-19 in dialysis units: A comprehensive review.

World journal of virology

Nogueira GM, Oliveira MS, Moura AF, Cruz CMS, Moura-Neto JA.
PMID: 34631476
World J Virol. 2021 Sep 25;10(5):264-274. doi: 10.5501/wjv.v10.i5.264.

The coronavirus disease 2019 (COVID-19) pandemic has been challenging for healthcare professionals worldwide. One of the populations affected by the pandemic are patients on renal replacement therapy, as kidney disease is an independent risk factor for severe COVID-19 and...

Cite
Nogueira GM, Oliveira MS, Moura AF, et al. COVID-19 in dialysis units: A comprehensive review. World J Virol. 2021;10(5):264-274doi: 10.5501/wjv.v10.i5.264.
Nogueira, G. M., Oliveira, M. S., Moura, A. F., Cruz, C. M. S., & Moura-Neto, J. A. (2021). COVID-19 in dialysis units: A comprehensive review. World journal of virology, 10(5), 264-274. https://doi.org/10.5501/wjv.v10.i5.264
Nogueira, Gabriel Martins, et al. "COVID-19 in dialysis units: A comprehensive review." World journal of virology vol. 10,5 (2021): 264-274. doi: https://doi.org/10.5501/wjv.v10.i5.264
Nogueira GM, Oliveira MS, Moura AF, Cruz CMS, Moura-Neto JA. COVID-19 in dialysis units: A comprehensive review. World J Virol. 2021 Sep 25;10(5):264-274. doi: 10.5501/wjv.v10.i5.264. PMID: 34631476; PMCID: PMC8474976.
Copy Download .nbib Format: NLM
Peptide-Functionalized Dendrimer Nanocarriers for Targeted Microdystrophin Gene Delivery.

Pharmaceutics

Hersh J, Condor Capcha JM, Iansen Irion C, Lambert G, Noguera M, Singh M, Kaur A, Dikici E, Jiménez JJ, Shehadeh LA, Daunert S, Deo SK.
PMID: 34959441
Pharmaceutics. 2021 Dec 15;13(12). doi: 10.3390/pharmaceutics13122159.

Gene therapy is a good alternative for determined congenital disorders; however, there are numerous limitations for gene delivery in vivo including targeted cellular uptake, intracellular trafficking, and transport through the nuclear membrane. Here, a modified G5 polyamidoamine (G5 PAMAM)...

Cite
Hersh J, Condor Capcha JM, Iansen Irion C, et al. Peptide-Functionalized Dendrimer Nanocarriers for Targeted Microdystrophin Gene Delivery. Pharmaceutics. 2021;13(12)doi: 10.3390/pharmaceutics13122159.
Hersh, J., Condor Capcha, J. M., Iansen Irion, C., Lambert, G., Noguera, M., Singh, M., Kaur, A., Dikici, E., Jiménez, J. J., Shehadeh, L. A., Daunert, S., & Deo, S. K. (2021). Peptide-Functionalized Dendrimer Nanocarriers for Targeted Microdystrophin Gene Delivery. Pharmaceutics, 13(12), . https://doi.org/10.3390/pharmaceutics13122159
Hersh, Jessica, et al. "Peptide-Functionalized Dendrimer Nanocarriers for Targeted Microdystrophin Gene Delivery." Pharmaceutics vol. 13,12 (2021). doi: https://doi.org/10.3390/pharmaceutics13122159
Hersh J, Condor Capcha JM, Iansen Irion C, Lambert G, Noguera M, Singh M, Kaur A, Dikici E, Jiménez JJ, Shehadeh LA, Daunert S, Deo SK. Peptide-Functionalized Dendrimer Nanocarriers for Targeted Microdystrophin Gene Delivery. Pharmaceutics. 2021 Dec 15;13(12). doi: 10.3390/pharmaceutics13122159. PMID: 34959441.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 59 entries